Private equity co Infinity invests in Chinese biopesticide maker

Private equity firm Infinity is investing $18 million (120 million RMB) in Chinese biopesticide maker Shijiazhuang Xingbai Pharmaceutical Company Limited.

Four of Infinity’s funds - the SJZ fund, the I-China fund, the Changzhou fund and the Tianjin fund - participated in this investment. The financing is earmarked to enhance Shijiazhuang Xingbai’s bio-tech capabilities with the goal of better competing on domestic and international markets. Shijiazhuang Xingbai is planning an IPO in the A-share market in three years.

Shijiazhuang Xingbai Pharmaceutical Company Limited, established in 2004 in China's Hebei province, is a manufacturer of biological pesticides.
Infinity life science managing director Dr. Bella Ohana said that Infinity appreciates the potential of Shijiazhuang Xingbai’s core business, calling the company a leader in the bio-pesticides market.

Infinity managing partner and founder Amir Gal-Or said, "Infinity will leverage its connections with the various modern bio-agricultural entities in Israel and use its IP bank platform to upgrade Shijiazhuang Xingbai’s technology and promote its brand worldwide.”